Drugs / iron polysaccharide complex
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT00248716 | Feb 2007 → Apr 2009 | iron deficiency anemia | Soroka University Medical Center | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01904864 Comparator | Jul 2013 → Nov 2015 | iron deficiency anemia | University of Texas Southwestern Medical Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | iron polysaccharide complex | “Three mg/kg of elemental iron once daily as either ferrous sulfate drops or iron polysaccharide complex drops for 12 weeks.” PMID 28609534 ↗ Jun 2017 |
| Known as | Ferripel-3 | “Groups 1 and 2 will randomly receive one of two preparations currently in use for treatment of iron deficiency in Israel (Aktiron 35 - Ferrous gluconate and Ferripel-3 - iron...” NCT00248716 ↗ |